Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Quoin Pharmaceuticals Ltd ADR (QNRX)

Quoin Pharmaceuticals Ltd ADR (QNRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Quoin Pharmaceuticals Ltd ADR 42127 Pleasant Forest Court Ashburn VA 20148 USA

https://quoinpharma.com Employees: 4 P: 703-980-4182

Description:

Quoin Pharmaceuticals is a specialty pharmaceutical company focused on rare and orphan diseases. Quoin Pharmaceuticals, formerly known as Cellect Biotechnology Ltd., is based in Tel Aviv.

Key Statistics

Overview:

Market Capitalization, $K 2,954
Enterprise Value, $K 554
Shares Outstanding, K 5,050
Annual Sales, $ 0 K
Annual Net Income, $ -8,690 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -2,350 K
EBIT, $ -9,350 K
EBITDA, $ -9,250 K
60-Month Beta 1.85
% of Insider Shareholders 3.70%
% of Institutional Shareholders 8.63%
Float, K 4,863
% Float 96.30%
Short Volume Ratio 0.20

Growth:

1-Year Return -86.55%
3-Year Return -99.88%
5-Year Return -99.96%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 99.61%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.47 on 11/07/24
Next Earnings Date N/A
Earnings Per Share ttm -4.05
EPS Growth vs. Prev Qtr -20.51%
EPS Growth vs. Prev Year 75.90%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-12 on 07/18/23

QNRX Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -125.60%
Return-on-Assets % -64.77%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 0.45
Book Value/Share 1.37
Interest Coverage -0.43
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar